中文
产品详情
产品名称 英文名称:GSK2126458 (GSK458) 同义词 Omipalisib、1086062-66-9、GSK2126458、GSK-2126458、2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide、GSK 2126458、2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide、GSK-212、2,4- 产品性质 CAS编号:1086062-66-9 分子式:C25H17F2N5O3S 分子量:505.5 EC号:629-873-1 PubChem编号:25167777 英文别名:Omipalisib|1086062-66-9|GSK2126458|GSK-2126458|2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide|GSK 2126458|2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide|GSK-212|2,4- 规格或纯度:≥98% 英文名称:GSK2126458 (GSK458) 生化机理:GSK2126458 (GSK458) is an orally active, highly potent and selective ATP site inhibitor against phosphoinositide 3-kinase (PI3K p110α CI50 = 40 pM; p100 α/δ/γ/β Ki = 19/24/60/130 pM; p110α E542K/E545K/H1047R Ki = 8/8/9 pM), mTOR (mTORC1/C2 Ki = 180/300 pM) and DNA-PK (IC50 = 280 pM) with >10,000-fold selectivity over more than 240 other kinases evaluated. GSK458 inhibits cellular AKT pS473 and growth of breast cancer cells in cultures (pAKT/growth IC50 = 0.41/3 nM/T-47D and 0.18/2.4/BT-474) and in vivo (0.3-3 mg/kg, 5x per wk for 3 wks p.o. in mice). 储存温度:-20°C储存 运输条件:超低温冰袋运输 备注:2mg卖完停产,不再备货 产品介绍:Omipalisib (GSK2126458, GSK458)是一种高选择性的,有效的p110α/β/γ/δ和 mTORC1/2抑制剂,无细胞试验中Ki分别为0.019 nM/0.13 nM/0.024 nM/0.06 nM和0.18 nM/0.3 nM。Omipalisib 可诱导自噬。GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2 , respectively. ALogP:3.3 IUPAC Name:2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide INCHI:InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3 InChi Key:CGBJSGAELGCMKE-UHFFFAOYSA-N Canonical SMILES:COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F Isomeric SMILES:COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F 关联CAS:1086062-66-9 PubChem CID:25167777 MeSH Entry Terms:2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide;GSK 212;GSK 2126458;GSK-212;GSK-2126458;GSK212;GSK2126458;omipalisib 溶解性:溶于DMSO, 最高浓度 (mg/mL) 10.11, 最高浓度(mM) 20 熔点:184-186°C 象形图: 信号词:Danger 危险声明:H301 Toxic if swallowedH341 Suspected of causing genetic defectsH372 Causes damage to organs through prolonged or repeated exposureH361 Suspected of damaging fertility or the unborn child 预防措施声明:P280,P321,P405,P501,P264,P260,P281,P270,P330,P203,P301+P316,P318,P319 产品包装
免责声明:以上所展示的信息由企业自行提供,内容的真实性
、准确性和合法性由发布企业负责,chemdig对此不承担任何保证责任。 同时我们郑重提醒各位买/卖家,
交易前 请详细核实对方身份,切勿随意打款或发货,谨防上当受骗。如发现虚假信息,请向chemdig举报。 |
上海阿拉丁生化科技股份有限公司
|
上海阿拉丁生化科技股份有限公司
| 邮箱 | market@aladdin-e.com |
| 联系人 | 18521732826 |
咨询请告知是在ChemDig上看到的,有助于交易达成。